Sector: MedicalAuxilium Pharmaceuticals, Inc. (NASDAQ: AUXL)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 245 |
Technical : | 204 |
Performance : | 244 |
Overall: | 276 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 248 |
Technical : | 168 |
Performance : | 248 |
Overall: | 270 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 249 |
Technical : | 229 |
Performance : | 249 |
Overall: | 290 |
Number of Stocks: | 305 |
Headlines
- Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results and Operational Highlights
Oct 28, 2009 07:01 AM | AUXL
- Repros Reports Androxal(R) Restores Normal Sperm Counts While Increasing Testosterone Levels in Hypogonadal Men
Oct 06, 2009 09:00 PM | AUXL, RPRX
- FDA Advisory Committee Unanimously Recommends Approval of XIAFLEX(TM) for Treatment of Dupuytren's Disease
Sep 16, 2009 05:11 PM | AUXL
- U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
Sep 16, 2009 03:46 PM | AUXL
- BioSpecifics Technologies Corp. Stock Trading Halted Today
Sep 16, 2009 07:29 AM | AUXL, PFE
- Ahead of the Bell: Sunwin International Neutraceuticals - September 15, 2009
Sep 15, 2009 08:38 AM | AUXL, DNDN, SUWN
- BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
Sep 03, 2009 05:41 PM | AUXL
- XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
Sep 02, 2009 05:05 PM | AUXL
- Partnerships And Mergers Updates : Wipro Partners with BP, Endo Buys US Rights to Fortesta, Siemens Buys China Metal, Google's Search for Italian Solution
Aug 28, 2009 02:15 PM | ABB, ADC, AUXL, BMY, ENDP, GE
- Be Prepared For These Huge Biotech Catalysts In September
Aug 21, 2009 11:21 AM | ALTH, AUXL, ENDP, ISTA, SPPI, THRX
- Auxilium Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
Nov 02, 2009 07:53 AM | AUXL
- Auxilium Pharmaceuticals to Announce Third Quarter 2009 Results and Conduct Conference Call on Wednesday, October 28, 2009
Oct 14, 2009 07:53 AM | AUXL
- Jefferies Expands International Healthcare Investment Banking Platform
Oct 05, 2009 05:54 AM | AUXL, IMA, JEF, QGEN, SEPR
- Auxilium Pharmaceuticals Completes Sale of 3.45 Million Shares of Common Stock Resulting in $115.7 Million in Net Proceeds
Oct 01, 2009 07:54 AM | AUXL
- Auxilium Pharmaceuticals, Inc. Announces Pricing of a Public Offering of Common Stock
Sep 25, 2009 09:53 AM | AUXL
- Auxilium Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Sep 08, 2009 07:51 AM | AUXL
- Auxilium Pharmaceuticals to Present at the Thomas Weisel Partners 2009 Healthcare Conference
Aug 27, 2009 07:00 AM | AUXL
- BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
Aug 12, 2009 05:17 PM | AUXL, PFE
- Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational Highlights
Aug 06, 2009 06:54 AM | AUXL, RX
- Auxilium Pharmaceuticals, Inc. Secures $30 Million Revolving Credit Line With Silicon Valley Bank
Aug 05, 2009 06:00 AM | AUXL, SIVB
- Form 4 LANGER DENNIS For: Sep 30 (10K)
Oct 02, 2009 08:52 PM
- Form 4 FUCHS RENATO For: Sep 30 (10K)
Oct 02, 2009 08:46 PM
- Form 4 FETZER OLIVER For: Sep 30 (10K)
Oct 02, 2009 08:40 PM
- Form 4 Stacey Jennifer Evans For: Sep 14 (10K)
Sep 16, 2009 08:55 PM
- Form 4 Graham Roger D Jr For: Sep 14 (10K)
Sep 16, 2009 08:54 PM
- Form 4 Fickenscher James E For: Sep 14 (10K)
Sep 16, 2009 08:53 PM
- Form 4 ANIDO ARMANDO For: Sep 11 (10K)
Sep 14, 2009 05:42 PM
- Form 4 Fickenscher James E For: Sep 08 (10K)
Sep 10, 2009 08:14 PM
- Form 4 Stacey Jennifer Evans For: Jul 24 (10K)
Jul 28, 2009 09:54 PM
- Form 4 Graham Roger D Jr For: Jul 24 (10K)
Jul 28, 2009 09:38 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AUXL
|
Compare to S&P
|
| YTD |
10.62 %
|
-3.57 %
|
| 4 Weeks |
-4.20 %
|
-5.22 %
|
| 12 Weeks |
7.70 %
|
5.03 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -9.38 %
|
|
EPS Growth in Last Year: -45.83 %
|
|
Sales Growth in Last Quarter: 7.52 %
|
|
Sales Growth in Last Quarter: 29.33 %
|
|
